北美神经调节市场预测至 2027 年 - COVID-19 影响和区域分析（按技术[外部（非侵入）神经调节和内部神经调节]、应用（慢性疼痛管理、腰背衰竭综合征、癫痫、震颤、失禁、抑郁、肌张力障碍、胃轻瘫、帕金森病、强迫症和偏头痛）以及最终用户（医院、诊所和家庭医疗保健）和国家/地区
No. of Pages: 108 | Report Code: TIPRE00016293 | Category: Life Sciences
No. of Pages: 108 | Report Code: TIPRE00016293 | Category: Life Sciences
神经调节是通过控制神经递质的生理水平来调节神经活动的过程。这些改变是在各种设备的帮助下或通过药物输注实现的。这些设备包含放置在脊髓、大脑或周围神经上的小电极。脑血管疾病、阿尔茨海默病和帕金森病等神经系统疾病会影响身体的神经功能，因此可以借助神经调节进行治疗。
北美神经调节市场预计将从 2019 年的 30.2972 亿美元增至 2027 年的 66.12 亿美元 ;预计2020年至2027年复合年增长率为10.6%。北美神经调节市场的增长归因于神经系统疾病发病率的增加以及神经调节技术的不断发展。然而，神经调节设备的高成本阻碍了该地区市场的增长。导致限制市场的增长。
基于技术，北美神经调节市场被细分分为外部（非侵入性）神经调节和内部神经调节。 2019年，内部神经调节细分市场占据了更大的市场份额。外部（非侵入性）神经调节预计在预测期内将以更快的速度增长。
雅培、波士顿科学公司、美敦力、NeuroPace, Inc.、NeuroSigma, Inc.、NEVRO CORP、Synapse Biomedical Inc.、Soterix Medical Inc、Integer Holdings Corporation 和 Magstim。
按技术划分
· ; 外部（非侵入性）神经调节
o 呼吸电刺激
o 经皮神经电刺激
o 经颅磁刺激
· 内部神经调节
o 深部脑刺激
o 骶神经刺激
o 胃电刺激
o 脊髓刺激
o 迷走神经刺激
按应用
· 慢性疼痛管理
· 失败恢复综合症
· 癫痫
· 震颤
· 失禁
· 抑郁症
· 肌张力障碍
· 胃轻瘫
· 帕金森病
· 强迫症
· 偏头痛
最终用户
· 医院
· 诊所
· 家庭医疗保健
按国家/地区
· 美国
· 加拿大
· 墨西哥
Strategic insights for North American Neuromodulation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 3,029.72 Million |
| Market Size by 2027 | US$ 6,612.00 Million |
| Global CAGR (2020 - 2027) | 10.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North American Neuromodulation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North American Neuromodulation Market is valued at US$ 3,029.72 Million in 2019, it is projected to reach US$ 6,612.00 Million by 2027.
As per our report North American Neuromodulation Market, the market size is valued at US$ 3,029.72 Million in 2019, projecting it to reach US$ 6,612.00 Million by 2027. This translates to a CAGR of approximately 10.6% during the forecast period.
The North American Neuromodulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North American Neuromodulation Market report:
The North American Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North American Neuromodulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North American Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North American Neuromodulation Market
